Bellus Fundamentals

BLU
 Stock
  

USD 11.35  0.61  5.10%   

Bellus Health fundamentals help investors to digest information that contributes to Bellus Health's financial success or failures. It also enables traders to predict the movement of Bellus Stock. The fundamental analysis module provides a way to measure Bellus Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellus Health stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
Bellus Health Gross Profit is comparatively stable at the moment as compared to the past year. Bellus Health reported Gross Profit of 16,000 in 2021. Interest Expense is likely to gain to about 56.4 K in 2022, whereas Net Income is likely to drop (73.1 M) in 2022.

Bellus Number of Shares Shorted Analysis

Bellus Health's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Shares Shorted 
 = 
Shorted by Public 
by Institutions 
More About Number of Shares Shorted | All Equity Analysis

Current Bellus Health Number of Shares Shorted

    
  15.53 M  
Most of Bellus Health's fundamental indicators, such as Number of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bellus Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Compare to competition

Based on the recorded statements, Bellus Health has 15.53 M of outstending shares currently sold short by investors. This is 385.43% higher than that of the Healthcare sector and 204.67% higher than that of the Biotechnology industry. The number of shares shorted for all United States stocks is significantly lower than that of the firm.

Bellus Health Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bellus Health's current stock value. Our valuation model uses many indicators to compare Bellus Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bellus Health competition to find correlations between indicators driving Bellus Health's intrinsic value. More Info.
Bellus Health is number one stock in net income category among related companies. It is number one stock in market capitalization category among related companies . Bellus Health Net Income is comparatively stable at the moment as compared to the past year. Bellus Health reported Net Income of (71.22 Million) in 2021. Comparative valuation analysis is a catch-all model that can be used if you cannot value Bellus Health by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bellus Health's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bellus Health's earnings, one of the primary drivers of an investment's value.
Bellus Health is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 121,140. Bellus Health adds roughly 40.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

Bellus Fundamentals

About Bellus Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Bellus Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellus Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellus Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Revenues16 K16.4 K
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bellus Health without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Performance Analysis Now

   

Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Pair Trading with Bellus Health

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bellus Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellus Health will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bellus Health

0.83ABCLAbcellera Biologics Downward RallyPairCorr
0.7ACXPAcurx Pharmaceuticals Earnings Call  TodayPairCorr
0.82ALLOAllogene Therapeutics Downward RallyPairCorr

Moving against Bellus Health

0.71ADMTAdm Tronics Unlimited Earnings Call  This WeekPairCorr
0.54AGTCApplied Genetic Tech Fiscal Year End 22nd of September 2022 PairCorr
The ability to find closely correlated positions to Bellus Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bellus Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bellus Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bellus Health to buy it.
The correlation of Bellus Health is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bellus Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bellus Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bellus Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Bellus Health Piotroski F Score and Bellus Health Altman Z Score analysis. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.5 B
Return On Assets
-0.22
Return On Equity
-0.37
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.